136 related articles for article (PubMed ID: 36534108)
1. The Impact of Exogenous Testosterone on Breast Cancer Risk in Transmasculine Individuals.
Gurrala RR; Kumar T; Yoo A; Mundinger GS; Womac DJ; Lau FH
Ann Plast Surg; 2023 Jan; 90(1):96-105. PubMed ID: 36534108
[TBL] [Abstract][Full Text] [Related]
2. The effect of testosterone on ovulatory function in transmasculine individuals.
Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
[TBL] [Abstract][Full Text] [Related]
3. HIV prevalence among transmasculine individuals at a New York City Community Health Centre: a cross-sectional study.
Radix AE; Larson EL; Harris AB; Chiasson MA
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25981. PubMed ID: 36225145
[TBL] [Abstract][Full Text] [Related]
4. Contraception across the transmasculine spectrum.
Krempasky C; Harris M; Abern L; Grimstad F
Am J Obstet Gynecol; 2020 Feb; 222(2):134-143. PubMed ID: 31394072
[TBL] [Abstract][Full Text] [Related]
5. Endometrial thickness assessed by transvaginal ultrasound in transmasculine people taking testosterone compared with cisgender women.
Asseler JD; Caanen MR; Verhoeven MO; Huirne JAF; Goddijn M; van Dulmen-den Broeder E; Overbeek A; Lambalk CB; van Mello NM
Reprod Biomed Online; 2022 Nov; 45(5):1033-1038. PubMed ID: 35918245
[TBL] [Abstract][Full Text] [Related]
6. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gomez-Lobo V; Gray M
Am J Obstet Gynecol; 2019 Mar; 220(3):257.e1-257.e7. PubMed ID: 30579875
[TBL] [Abstract][Full Text] [Related]
7. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 35831234
[TBL] [Abstract][Full Text] [Related]
8. Toker Cell Hyperplasia in the Nipple-Areolar Complex of Transmasculine Individuals.
Baker GM; Bret-Mounet VC; Xu J; Fein-Zachary VJ; Tobias AM; Bartlett RA; Clohessy JG; Vlachos IS; Massicott ES; Wulf GM; Schnitt SJ; Heng YJ
Mod Pathol; 2023 Jun; 36(6):100121. PubMed ID: 36889065
[TBL] [Abstract][Full Text] [Related]
9. Masculinizing hormone therapy effect on breast tissue: Changes in estrogen and androgen receptors in transgender female-to-male mastectomies.
Chaum M; Grossi S; Chen J; Hu V; Ray E; Giuliano A; Bose S
Breast; 2023 Dec; 72():103596. PubMed ID: 37951051
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gray M; Gomez Lobo V
J Sex Med; 2020 Sep; 17(9):1807-1818. PubMed ID: 32703706
[TBL] [Abstract][Full Text] [Related]
11. Serum estradiol levels decrease after oophorectomy in transmasculine individuals on testosterone therapy.
Kumar S; Bertin E; O'Dwyer C; Khorrami A; Wassersug R; Mukherjee S; Mehra N; Dahl M; Genoway K; Kavanagh AG
Asian J Androl; 2023; 25(3):309-313. PubMed ID: 36124534
[TBL] [Abstract][Full Text] [Related]
12. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 37051961
[TBL] [Abstract][Full Text] [Related]
13. Testosterone and breast cancer prevention.
Glaser R; Dimitrakakis C
Maturitas; 2015 Nov; 82(3):291-5. PubMed ID: 26160683
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein subtypes after testosterone therapy in transmasculine adolescents.
Millington K; Chan YM
J Clin Lipidol; 2021; 15(6):840-844. PubMed ID: 34657833
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Mortality Among Transgender and Gender Diverse Adults in England.
Jackson SS; Brown J; Pfeiffer RM; Shrewsbury D; O'Callaghan S; Berner AM; Gadalla SM; Shiels MS
JAMA Netw Open; 2023 Jan; 6(1):e2253687. PubMed ID: 36716027
[TBL] [Abstract][Full Text] [Related]
17. Prostatic metaplasia of the vagina in transmasculine individuals.
Xu R; Diamond DA; Borer JG; Estrada C; Yu R; Anderson WJ; Vargas SO
World J Urol; 2022 Mar; 40(3):849-855. PubMed ID: 35034167
[TBL] [Abstract][Full Text] [Related]
18. ESTROGEN LEVELS DO NOT RISE WITH TESTOSTERONE TREATMENT FOR TRANSGENDER MEN.
Chan KJ; Jolly D; Liang JJ; Weinand JD; Safer JD
Endocr Pract; 2018 Apr; 24(4):329-333. PubMed ID: 29561193
[TBL] [Abstract][Full Text] [Related]
19. Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy.
Leemaqz SY; Kyinn M; Banks K; Sarkodie E; Goldstein D; Irwig MS
J Clin Lipidol; 2023; 17(1):103-111. PubMed ID: 36473821
[TBL] [Abstract][Full Text] [Related]
20. Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy.
Humble RM; Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2022 Sep; 7(5):1131-1144. PubMed ID: 35584132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
